Australia
Austria
Belgium
China
Czech Republic
Denmark
Estonia
Finland
France
Germany
Hungary
India
Ireland
Italy
Japan
Kazakhstan
Latvia
Lithuania
Malaysia
Netherlands
Norway
Poland
Singapore
Slovenia
Spain
Sweden
Thailand
UK
Ukraine
Investors
This section contains information about Orion as an investment.
Stock exchange releases
- 10/29/2024 Orion Group Interim Report January–September 2024
- 10/24/2024 Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule
- 9/20/2024 213,285 Orion Corporation A shares converted into B shares
- 9/11/2024 Inside information: Orion upgrades full-year outlook for 2024
Press releases
- 11/22/2024 Orion Research Foundation grants EUR 1,109,000 for research in 2025
- 11/19/2024 Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
- 10/15/2024 Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024
- 10/14/2024 Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU
